Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Biogen reported adjusted Q3 2026 EPS of $2.62 and revenue of $2.80 billion, above FactSet consensus estimates of $1.99 and $2.63 billion, respectively. It raised the low end of its fiscal 2026 non-GAAP EPS guidance to $12.20, with a range of $12.20 to $13.00.
For best results when printing this announcement, please click on link below: RNS Number: 0622W BioPharma Credit PLC 24 September 2026 24 September 2026 BIOPHARMA CREDIT PLC ("BPCR" or "the Company") HALF YEAR REPORT FOR THE YEAR ENDED 30 JUNE 2026 BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt inv